The White Lie
- anwerjan
- Jun 3
- 26 min read
How Britain Degraded Its Milk, Destroyed Its Dairy Farmers and Never Told the Consumer
National Health Restoration Series — Article 10
In 1980, there were more than 100,000 dairy farms in the United Kingdom [1]. By the year 2000, that number had already collapsed to approximately 28,000 [2]. As of October 2024, the Agriculture and Horticulture Development Board (AHDB) estimates that just 7,200 commercial dairy producers remain in Great Britain, with approximately 190 farms exiting the industry in the twelve months to April 2025 alone [3,4]. The AHDB projects that the number of viable dairy farms will fall below 5,500 by 2030 [4]. That is a decline of more than 93% in half a century. It is one of the most rapid structural collapses of a domestic food production sector anywhere in the developed world. And the bottle of milk sitting in your fridge carries no trace of it.
The white bottle with the supermarket's own label tells you nothing about how the cow was kept. It does not tell you whether that cow ever stood in a field. It does not tell you whether it was treated with antibiotics during the lactation that produced the milk you are about to pour into your child's cereal. It does not tell you whether the protein in that milk is compositionally the same as the milk your parents drank, or whether it contains a beta-casein variant that releases an opioid peptide during digestion that has been linked in peer-reviewed research to gut inflammation, delayed intestinal transit and symptoms indistinguishable from lactose intolerance [5,6]. It does not tell you that the cow that produced it may have spent its entire productive life indoors, in a herd of more than a thousand animals, on a concrete floor, producing in excess of 10,000 litres of milk per year before being culled at a fraction of its natural lifespan [7]. The label tells you the fat content. It tells you the use-by date. It tells you it is "British." That is all.
This is the eleventh article in the Restoring Britain's Health series. We have examined what industrial processing has done to British chicken [8], to bread [9], to meat [10], to breakfast cereal, to beer, and to the water that comes out of British taps. In every case, the same pattern has emerged: a staple food or resource, trusted by the public on the basis of assumptions that are decades out of date, quietly transformed by industrial consolidation, supermarket price pressure and regulatory indifference, with consequences for nutrition and public health that remain undisclosed and largely unexamined. Milk is perhaps the most powerful example of all, because no food in Britain carries a stronger health reputation, and no food has been more thoroughly transformed while maintaining the appearance of continuity.
Part One: The Collapse of British Dairy Farming
The numbers are stark and they are not disputed. The United Kingdom had an estimated 28,000 dairy farms at the turn of the millennium [2]. The AHDB's most recent producer survey, conducted in October 2024, estimated 7,200 active commercial dairy producers in Great Britain [3]. The Bullvine, citing AHDB data, reports that UK dairy producer numbers have decreased by approximately 70% over the last thirty years, with cow numbers declining around 28% since the mid-1990s [11]. The farms that remain are larger. The average milk volume per farm in Great Britain has now risen to 1.7 million litres per year [3]. Average herd sizes have increased to approximately 165 cows, according to the 2024 Defra Agricultural Census [4]. In the 1980s, a typical dairy herd numbered between 50 and 80 animals. The industry has not shrunk; it has consolidated. Fewer farms are producing more milk per unit, and the family dairy farm as a commercially viable enterprise is being driven to extinction.
The regional pattern of this collapse tells its own story. Food Standards Agency data analysed by the AHDB shows that the largest losses of producers in the year to April 2024 occurred in the North West of England (39 farms), the North of England (22), the Midlands (16) and the Mid West including Devon, Somerset and Wiltshire (13) [12]. These are the regions where dairy farming was once a backbone of rural economic and social life. The AHDB's own senior analyst, Freya Shuttleworth, has stated that although milk prices are historically higher in nominal terms, when compared with the peaks in 2022 they have fallen substantially, while continued inflationary pressure on key inputs, including feed, fuel and energy, and increased interest rates driving up the cost of borrowing, have incentivised producers to leave the industry as margins tighten [12]. As of June 2024, the average UK farmgate milk price was 38.43 pence per litre, which was 13.08p less than the highest price paid in 2022 [12].
The processing and retail end of the supply chain, by contrast, is dominated by a small number of very large players. Arla Foods, a European dairy cooperative, is the largest milk buyer in the UK. Müller, a German-owned company, is the second. Dairy Crest, once a major British processor, was acquired by the Canadian company Saputo in 2019. These processors set the terms on which farmers sell their milk, and those terms are dictated in turn by the price at which supermarkets are willing to buy. The supermarket milk price has functioned for decades as a loss-leader: a product sold at or below cost to attract shoppers through the door. The human cost of this pricing strategy has been borne almost entirely by the farmer. Between 2014 and 2016, farmgate milk prices fell to levels at which a significant proportion of British dairy farmers were being paid below the cost of production [1]. The 2021 RABI Big Farming Survey found that 36% of the farming community in the UK were "probably" or "possibly" depressed [13]. In 2024, the Office for National Statistics recorded 47 suicides among people working in farming and agriculture in England and Wales [14]. The Farm Safety Foundation reports that male farm workers are three times more likely to take their own lives than the male national average [15]. The mental health crisis in British farming is not an incidental feature of the dairy industry's transformation. It is a direct consequence of it.
Part Two: The Mega-Dairy and the End of Pasture
The cows that produce most British supermarket milk today are not, for the most part, the animals that appear on the packaging. The bucolic imagery of green fields and contented Friesians that adorns virtually every supermarket milk carton in the country is, for an increasing proportion of British milk production, a misrepresentation. There is no legal requirement for milk labels to disclose whether the cows that produced the milk had access to pasture, how large the herd was, or what production system was used [16]. The consumer has no way of distinguishing, from the label, between milk from a pasture-fed cow on a 100-head family farm and milk from a zero-grazed Holstein in a 2,000-head indoor unit.
The Nocton Dairies controversy of 2009 to 2011 brought the mega-dairy question into public view for the first time. Nocton Dairies Ltd, formed by Devon farmer Peter Willes and Lancashire producer David Barnes, submitted a planning application to North Kesteven District Council in December 2009 for an 8,100-cow dairy at Nocton Heath in Lincolnshire [17]. The proposal attracted immediate and intense opposition. An Early Day Motion signed by 172 MPs was tabled in the House of Commons [17]. An Ipsos MORI survey commissioned by the World Society for the Protection of Animals found that 61% of British consumers said they would never knowingly buy milk produced in large-scale indoor dairy sheds [18]. Compassion in World Farming launched its "Cows Belong in Fields" campaign [19]. The original application was withdrawn in April 2010 after the Environment Agency raised objections regarding groundwater pollution risk [17]. A revised application for 3,770 cows was submitted in November 2010 but was withdrawn in February 2011, again on environmental grounds [20]. The proposals were defeated. But the conditions that made them attractive to investors have not changed; if anything, they have intensified.
What the Nocton controversy revealed, and what the industry has since preferred to obscure, is that large-scale indoor dairy production was already well established in Britain before Nocton was ever proposed. A number of supermarkets that publicly distanced themselves from Nocton milk were found to be already sourcing from large indoor-based UK dairy farms [17]. The proliferation of units housing 500, 1,000 or more cows has continued, often beneath the planning threshold that attracts public scrutiny. The average herd size continues to rise. The proportion of British dairy cows that spend the majority of their lives indoors, fed total mixed ration (TMR) diets rather than grazing pasture, has increased steadily. And there is no legal minimum grazing requirement for dairy cows in the United Kingdom [16]. Zero-grazing, in which cows never access pasture, is entirely lawful.
The physical consequences for cows in high-yield intensive systems are well documented. An EU report on the animal welfare effects of recombinant bovine somatotropin (rBST), which analysed the conditions in intensive dairy systems more broadly, found that intensive management is associated with serious mastitis, foot disorders and reproductive problems [21]. Compassion in World Farming has noted that high-yielding cows producing 10,000 or more litres of milk per year expend energy equivalent to a human running a half marathon every day for ten months of the year [19]. The productive lifespan of a modern high-yield dairy cow is approximately three to four lactations before culling, compared with the ten or more years that a cow managed under traditional lower-yield systems might have produced [22]. These are not the cows on the carton.
Part Three: Antibiotics, Residues and the Resistance Crisis
The routine use of antibiotics in British dairy farming is one of the least discussed and most consequential aspects of milk production. The practice of blanket dry cow therapy (BDCT), in which every cow in a herd receives intramammary antibiotic treatment at the end of lactation regardless of whether she shows any sign of infection, has been a standard management practice on British dairy farms for decades [23]. A 2022 review published in the Journal of Dairy Science described BDCT as a "mainstay of mastitis prevention and control" with adoption rates of 75% to 99% depending on the country [24]. The University of Minnesota Extension service has estimated that BDCT accounts for approximately one-third of total antibiotic use on a conventional dairy farm [25]. This is not targeted therapeutic use. It is prophylactic mass medication.
The shift towards selective dry cow therapy (SDCT), in which only cows with a high probability of infection receive antibiotics while the remainder receive teat sealant alone, has been promoted by RUMA (Responsible Use of Medicines in Agriculture Alliance) and is reflected in updated guidelines. The CAFRE (College of Agriculture, Food and Rural Enterprise) reported in 2024 that the current level of antibiotic use in UK dairy cattle is estimated at 12.7 mg per population correction unit, which is below the RUMA target of 17.9 mg [26]. However, uptake of selective dry cow therapy remains inconsistent. One UK dairy farmer quoted in an MSD Animal Health report stated candidly: "At the moment, we are not using selective dry cow therapy, and use antibiotics at drying off on all cows" [27]. The gap between industry guidance and on-farm practice is significant.
The Veterinary Medicines Directorate (VMD) publishes the UK-VARSS (Veterinary Antibiotic Resistance and Sales Surveillance) report annually. The 2023 report, published in November 2024, showed that sales of antibiotics for food-producing animals have fallen 59% since 2014 [28]. Sales of antibiotics classified as of highest critical importance to human health, including fluoroquinolones and third- and fourth-generation cephalosporins, account for less than 0.5% of total veterinary antibiotic sales [28]. The 2023 report was also the first to include AMR surveillance data from dairy cattle, through the PATH-SAFE programme. It found that 86% of E. coli isolates from dairy cattle were fully susceptible to all antibiotics tested [29]. These headline figures are encouraging. But they must be read carefully. Sales data is an overestimate of use because not all antibiotics sold are administered. Conversely, farm-level use data for the ruminant sector remains incomplete; the Medicine Hub, a voluntary data collection system launched in 2021, does not yet cover the entire dairy sector [30]. The overall direction is positive. The granularity is insufficient to conclude that the problem is solved.
The antimicrobial resistance (AMR) dimension is the one that connects dairy farming to the wider public health emergency. The UK's five-year National Action Plan on AMR, published in 2019, and the successor 2024 to 2029 plan, both identify agricultural antibiotic use as a driver of resistance [28]. As examined in the meat article in this series, the WHO classifies fluoroquinolones and third- and fourth-generation cephalosporins as critically important antimicrobials for human medicine [10]. Their use in livestock, including dairy cattle, creates selection pressure for resistant bacteria that can transfer to humans through the food chain, through environmental contamination and through direct contact. The 2023 UK-VARSS report found that 24% of clinical E. coli isolates from cattle were resistant to four or more individual antibiotics [29]. That figure deserves to be read twice.
Part Four: Growth Hormones and the rBST Question
Recombinant bovine somatotropin (rBST), also known as recombinant bovine growth hormone (rBGH), is a synthetic hormone injected into dairy cows to increase milk production by approximately 10 to 16% [31,32]. It was approved by the US Food and Drug Administration in 1993 and is marketed under the brand name Posilac [32]. It is banned in the United Kingdom and across the European Union, and has been since 1990 [32]. It is also banned in Canada, Australia, New Zealand, Japan, Argentina and Israel [32]. The Codex Alimentarius Commission has failed to reach consensus on maximum residue limits for rBST in dairy products, suspending consideration of the matter entirely [33].
The EU's decision to ban rBST was based primarily on animal welfare grounds. A 1999 EU Scientific Committee report found that rBST use "often results in severe and unnecessary pain, suffering and distress" for treated cows, and is associated with significantly increased rates of mastitis, lameness and reproductive disorders [32]. The Center for Food Safety in the United States has reported that rBST-treated cows experience a 50% increase in the risk of lameness and over a 25% increase in the frequency of udder infections requiring antibiotic treatment [34]. Because rBST increases mastitis, it also increases antibiotic use, creating a compounding effect on both animal welfare and antimicrobial resistance.
The human health concern centres on insulin-like growth factor 1 (IGF-1). rBST increases milk production by stimulating IGF-1, and elevated levels of IGF-1 have been detected in milk from rBST-treated cows [35]. The American Cancer Society has acknowledged that numerous studies demonstrate that high circulating levels of IGF-1 in humans are associated with an increased risk of cancers of the breast, prostate and colon [35]. Canadian and European regulators found that the FDA failed to consider a study showing that increased IGF-1 in rBGH milk could survive digestion and enter the intestines and bloodstream of consumers [34]. The scientific debate is not settled, but the precautionary principle applied by the EU and UK is defensible. What is less defensible is the failure to communicate to British consumers that this ban exists, what it protects them from, and that it is vulnerable.
Following the UK's departure from the European Union and the Customs Union, the UK has been free to negotiate bilateral trade agreements with countries where rBST is legal, most notably the United States. US dairy industry lobby groups have consistently sought the removal of the rBST ban as a condition of trade liberalisation [36]. This is the dairy equivalent of the chlorinated chicken debate that dominated post-Brexit food standards discussions. A 2021 analysis noted that with the UK government keen to make a flagship trade deal to make a positive statement around Brexit, US dairy products from rBST-treated cows could undercut UK produce [36]. The May 2025 US-UK trade framework prompted renewed concern, with British officials insisting that hormone-treated meat would not enter the UK market [37]. But the pressure is ongoing, and the regulatory distance between the UK and EU food standards continues to widen. British consumers are, for the most part, entirely unaware that the ban exists, let alone that it is under sustained trade pressure.
Part Five: A1 and A2 Casein, the Debate Britain Will Not Have
Beta-casein is the primary protein in cow's milk, accounting for approximately 30% of total milk protein [38]. It exists in two principal genetic variants: A1 and A2. The difference between them is a single amino acid substitution at position 67 of the protein chain: histidine in A1, proline in A2 [38]. This substitution has a significant functional consequence. During gastrointestinal digestion, the histidine at position 67 in A1 beta-casein renders the protein susceptible to enzymatic cleavage, releasing a seven-amino-acid opioid peptide called beta-casomorphin-7 (BCM-7) [5]. The proline at position 67 in A2 beta-casein resists this cleavage. A2 milk does not release BCM-7 during normal digestion [5,6].
BCM-7 is a known agonist of mu-opioid receptors, which are abundantly expressed in the enteric nervous system and regulate gut motility, mucus secretion and hormone production [6]. The published research on the gastrointestinal effects of A1 versus A2 beta-casein is substantial and growing. A landmark 2016 randomised, crossover, double-blind trial conducted in China by Jianqin et al., published in Nutrition Journal, found that consumption of milk containing A1 and A2 beta-casein (conventional milk) was associated with increased small intestine inflammation, elevated serum inflammatory biomarkers and increased serum BCM-7 concentrations compared with A2-only milk [39]. A2 milk consumption did not produce these effects. The same study found that conventional milk significantly prolonged colonic and overall gastrointestinal transit time compared with A2 milk [39].
A 2024 randomised, double-blind, crossover trial published in PMC found that subjects consuming A2 milk experienced reduced gastrointestinal discomfort symptoms compared with those consuming regular A1/A2 milk [40]. A comprehensive scoping review published in Applied Sciences in 2025 concluded that the evidence suggests consumption of milk containing A1 beta-casein may negatively influence gut health by altering microbial composition, reducing intestinal motility, increasing colonic fermentation and compromising intestinal barrier integrity [5]. These effects may exacerbate symptoms in individuals with irritable bowel syndrome (IBS) or functional gastrointestinal disorders, and may explain why some individuals who believe themselves to be lactose intolerant can tolerate A2 milk without difficulty [5,39].
This matters for British consumers because the dominant dairy breed in the UK, the Holstein-Friesian, produces predominantly A1 beta-casein [6]. Traditional British dairy breeds, including Guernsey, Jersey and Brown Swiss, produce predominantly A2 milk [6]. The wholesale shift from these heritage breeds to high-yield Holsteins over the past forty years, driven by yield maximisation, has had compositional consequences that the public has never been informed about. Virtually all standard infant formula is derived from A1-dominant cow's milk [41]. The a2 Milk Company markets A2-only milk in the UK, and the commercial success of that product is itself evidence of an unmet consumer need. Yet the Food Standards Agency (FSA) and EFSA have not engaged substantively with the A1/A2 literature. A 2008 EFSA review acknowledged that BCM-7 was an opioid peptide released by A1 but not A2, but concluded that the evidence for physiological effects in humans was insufficient at that time [41]. That was seventeen years and several dozen peer-reviewed studies ago. The regulatory position has not been updated. There is no labelling requirement disclosing whether milk is A1, A2 or mixed. The consumer is told nothing.
Part Six: The Nutritional Degradation of British Milk
The milk on the supermarket shelf in 2025 is not nutritionally the same product as the milk that a British family would have consumed in 1985. This is not a matter of opinion. It is a consequence of documented changes in breed composition, feeding systems and industrial processing.
The shift from traditional dual-purpose or Channel Island breeds to high-yield Holsteins has affected the fatty acid profile of British milk. A comprehensive review published in Nutrients in 2019 found that milk from pasture-fed cows has significantly higher concentrations of omega-3 polyunsaturated fatty acids, vaccenic acid and conjugated linoleic acid (CLA), while containing lower levels of omega-6 fatty acids and palmitic acid, compared with milk from cows fed total mixed ration (TMR) diets in housed systems [42]. Research published in the Journal of Dairy Science found that pasture-fed cows produced milk with more than double the concentration of CLA compared with TMR-fed cows: 1.38 versus 0.58 grams per 100 grams of milk fat [43]. A collaborative study involving the University of Minnesota, Johns Hopkins University and Newcastle University found that grass-fed milk provides a 147% increase in omega-3 fatty acids compared with conventional milk, and that the omega-6 to omega-3 ratio in grass-fed milk approaches 1:1, compared with 5.7:1 in conventional whole milk [44].
CLA is of particular interest because it has been associated in research with anti-inflammatory, anti-obesity and anti-carcinogenic properties [44]. Omega-3 fatty acids are associated with reduced cardiovascular disease risk and improved neurological function [45]. The fatty acid profile of milk is determined primarily by what the cow eats. Cows grazing diverse pasture, particularly pasture including clover and other legumes, produce milk with a markedly superior fatty acid profile compared with cows consuming cereal-based concentrates and conserved forages [45,46]. As the proportion of British dairy cows that are housed year-round and fed TMR diets has increased, the nutritional quality of the average pint of British milk has, by this measure, declined. The consumer is not informed of this. There is no labelling requirement distinguishing pasture-fed from indoor-produced milk.
Beyond fatty acids, the standardisation process itself removes nutritional value. Virtually all commercial milk in the United Kingdom has its fat content adjusted mechanically. Whole milk is standardised to a minimum 3.5% fat; semi-skimmed to between 1.5% and 1.8%; skimmed to no more than 0.5%. This is not the milk as it left the cow. The fat that is removed takes with it fat-soluble vitamins, including vitamin A, vitamin D and vitamin K2. Vitamin K2, which is produced by bacterial fermentation in the rumen and concentrated in milk fat from pasture-fed animals, plays a role in calcium metabolism and cardiovascular health [47]. The consumer who purchases semi-skimmed milk, as the majority of British households do, receives a product from which a significant portion of the nutritional value naturally present in whole, pasture-fed milk has been mechanically extracted.
Part Seven: Pasteurisation, Homogenisation and What Is Lost
All commercially sold liquid milk in the United Kingdom is pasteurised. The public health justification for pasteurisation is well established: heat treatment eliminates pathogenic bacteria including E. coli O157, Listeria monocytogenes, Campylobacter and Salmonella that can be present in raw milk [48]. This is not in serious dispute. Raw milk sold directly from the farm or at farmers' markets in England and Wales is legal but carries mandatory warning labels and cannot be sold through conventional retail [48]. The pathogen risk is real.
What is less well communicated is the growing body of evidence on what pasteurisation removes. The European GABRIELA study, published in the Journal of Allergy and Clinical Immunology in 2011, studied 8,334 school-aged children in rural regions of Germany, Austria and Switzerland. It found that reported raw milk consumption was inversely associated with asthma (adjusted odds ratio 0.59), atopy (aOR 0.74) and hay fever (aOR 0.51), independent of other farm exposures [49]. Boiled farm milk did not show a protective effect [49]. The PARSIFAL study, which examined nearly 15,000 children across five European countries, found a similar significant inverse association between farm milk consumption and childhood asthma [50]. A 2019 meta-analysis of eight studies published in the Journal of Allergy and Clinical Immunology: In Practice confirmed the protective effect of raw milk on asthma (OR 0.58), current wheeze (OR 0.66), hay fever (OR 0.68) and atopic sensitisation (OR 0.76), and found that this effect was present in both farm and non-farm children [51]. The GABRIELA study identified whey proteins, specifically alpha-lactalbumin, beta-lactoglobulin and bovine serum albumin, as the milk constituents most strongly associated with asthma protection, and these proteins are denatured by the temperatures used in pasteurisation [49].
The researchers behind both the GABRIELA and PARSIFAL studies were careful to emphasise that, on the basis of current knowledge, raw milk consumption cannot be recommended because of the pathogen risk [49,50]. This is a responsible position. But it also means that the health benefits associated with unprocessed milk, benefits observed consistently across multiple large European studies, are effectively inaccessible to consumers who buy their milk from a shop. The question of whether a minimally processed, microbiologically safe milk product could be developed to preserve these bioactive compounds is the subject of the ongoing MARTHA (Milk Against Respiratory Tract Infections and Asthma) clinical trial [51]. No such product is currently available in British retail.
Commercial milk is also universally homogenised: a mechanical process that forces milk under high pressure through small orifices, breaking fat globules into smaller particles to prevent cream separation. The hypothesis, advanced most notably by the American researcher Kurt Oster in the 1970s, that homogenised fat particles are absorbed differently and may facilitate the delivery of the enzyme xanthine oxidase into the arterial wall, with potential implications for cardiovascular disease, remains scientifically contested and has not been confirmed by subsequent research [52]. What is not contested is that homogenisation changes the physical structure of milk fat, and that this change is not disclosed to the consumer. The label on a bottle of British milk does not state that it has been homogenised. It does not state that it has been standardised. It does not state what has been removed or altered. It says "milk."
Part Eight: The Regulatory Void
British milk is overseen by a patchwork of regulatory bodies, none of which appears to have primary responsibility for the questions that matter most to the consumer. The Food Standards Agency (FSA) is responsible for food safety. The Animal and Plant Health Agency (APHA) handles disease surveillance. The Veterinary Medicines Directorate (VMD) monitors antibiotic use and residues. The Agriculture and Horticulture Development Board (AHDB), funded by a statutory levy on farmers, functions as an industry body providing market data and technical support [2,3]. None of these bodies is tasked with ensuring that the consumer knows how their milk was produced.
The Red Tractor Assurance scheme is the UK's largest farm standards programme, and approximately 95% of British milk is Red Tractor assured [53]. Red Tractor certification requires safe and hygienic housing, traceability, trained and competent staff, and proactive management of animal health and welfare [53]. What Red Tractor does not require is outdoor access. It does not require any minimum grazing period. It does not limit herd size. It does not prohibit zero-grazing. It does not prohibit the use of GM animal feed [16]. Red Tractor, in the assessment of Ethical Consumer, "merely guarantees that milk was produced on a UK farm that met Red Tractor Farm Assurance Dairy standards, the UK and EU legal minimum" [16]. The gap between what the consumer believes the Red Tractor logo signifies and what it actually certifies is substantial.
The RSPCA Assured scheme sets somewhat higher standards, encouraging outdoor grazing where weather permits and prohibiting some practices including embryo transfer [16]. Organic certification, under the Soil Association or equivalent bodies, requires access to pasture for most of the year, prohibits the routine use of antibiotics and bans GM feed [16]. The Pasture for Life standard, operated by the Pasture-Fed Livestock Association, explicitly prohibits zero-grazing and the feeding of soya and GM feed [16]. These higher-welfare standards are available but represent a small fraction of the market. The vast majority of British supermarket milk is produced under Red Tractor standards, which is to say, under the legal minimum, with no enforceable welfare standards beyond those that apply to any commercially kept bovine animal in the United Kingdom.
The consequence is a labelling void. A British consumer standing in a supermarket aisle cannot determine, from anything printed on the bottle, whether the milk was from a grazed or housed cow, whether the cow was fed pasture or TMR, what breed the cow was, how large the herd was, what antibiotic treatments were administered during that lactation, or whether the milk is A1, A2 or mixed. This is not an omission. It is a regulatory choice. The information exists. The decision has been made not to require its disclosure.
Part Nine: The Environmental Cost
The environmental footprint of intensive dairy farming in Britain is substantial and directly parallel to the river pollution crisis examined in the waterways article in this series [54]. Slurry and effluent from large dairy units are a major source of water pollution. Nitrate leaching from dairy-grazed land contaminates groundwater and contributes to eutrophication of rivers and lakes. The Environment Agency's objections to the Nocton mega-dairy proposal were specifically based on the risk of groundwater pollution from such a large concentration of cattle waste [20]. Those objections stopped one farm. They did not address the cumulative pollution from hundreds of large dairy units already operating across the country.
Dairy cattle are a significant source of UK agricultural greenhouse gas emissions. Methane, produced by enteric fermentation in the rumen, and nitrous oxide, released from manure and fertilised grassland, are the principal dairy-related emissions. The irony of the environmental case for intensive dairy farming is that it is used to justify conditions that the majority of British consumers would reject if they were aware of them. The argument, advanced by industry bodies and some agricultural economists, is that higher-yield cows produce more milk per unit of methane emitted, meaning that fewer cows are needed to produce the same volume of milk [55]. This is technically correct at the level of individual cow efficiency. It does not account for the ecological consequences of the shift from traditional mixed farming systems, which supported diverse pasture, hedgerows, wildflower meadows and the biodiversity they sustained, to intensive dairy monoculture based on imported feed concentrates and housed cattle.
Part Ten: The Price War and the Farmer
The British supermarket milk price is one of the most effective instruments of economic destruction in the modern food system. It is not an accident. It is a deliberate strategy. Milk is priced as a loss-leader to drive footfall, and the cost of this strategy is externalised to the farmer. Between 2014 and 2016, farmgate prices fell to levels at which significant numbers of British dairy farmers were being paid below the cost of production for extended periods [1,12]. The structural impossibility of a small family dairy farm competing with a 2,000-cow mega-unit on supermarket contract terms is not a market failure. It is a market outcome, produced by a system designed to deliver the lowest possible consumer price with no meaningful consideration of what that price costs the producer.
The deliberate consumer misdirection is perhaps the most troubling element. The bucolic imagery on milk cartons, the invocations of British farming heritage in supermarket advertising, the photographs of named farmers and rolling green fields, all exist alongside an economic reality in which the kind of farming depicted in those images is being systematically made unviable by the purchasing practices of the companies that use those images. The consumer who buys a supermarket own-label pint of milk for 65 pence, believing that their purchase supports a traditional family farm, is being deceived. Not by any single false claim, but by a comprehensive apparatus of visual and narrative misdirection that conceals the industrial reality behind a pastoral facade.
The parliamentary record reflects the gravity of the situation. A November 2024 debate in Westminster Hall on mental health in farming and agricultural communities heard from MPs representing dairy-intensive constituencies who described the suicide rate among farmers as "tragically high" and linked it directly to financial pressures, policy uncertainty and the erosion of farming communities [56]. The Farm Safety Foundation has described mental health as "the biggest hidden problem" facing UK agriculture, with 94% of farmers under 40 agreeing with that assessment [13,14]. In 2018, 83 suicides were registered among agricultural and related industries' workers in England and Wales [57]. The Zero Suicide Alliance has stated that three people in the UK farming and agricultural industry die by suicide every week [15]. These are the human consequences of the supermarket price war. They are not disclosed on the label either.
Part Eleven: International Comparison
Britain's approach to dairy labelling and production standards is, by international comparison, remarkably opaque. France's appellation system provides regional dairy identity and production traceability. Several EU member states require disclosure of production systems for dairy products. The Nordic countries apply higher baseline welfare standards, including more prescriptive requirements on housing and outdoor access. New Zealand's dairy industry is built almost entirely on a pasture-based system, producing milk with a markedly different fatty acid and protein profile from that of housed, concentrate-fed British Holsteins [42].
The specific post-Brexit trade risks to British dairy standards cannot be overstated. The US dairy industry has made the removal of the rBST ban a consistent objective in trade negotiations [36,37]. The regulatory distance between the UK and the EU continues to widen. The EU retains a regulatory floor under dairy production standards. The UK, having departed from the single market, has no equivalent binding framework. The Animal Welfare (Kept Animals) Bill, which might have addressed some of these gaps, was abandoned. The Genetic Technology (Precision Breeding) Act 2023 has created a regulatory pathway for gene-edited livestock that diverges from EU rules. The direction of travel is towards less regulation, not more. For British dairy consumers, this means that the protections they assume are in place, because they were in place when the UK was an EU member, may not survive the next round of trade negotiations.
Questions Nobody Is Asking
Why is there no mandatory labelling requirement on British milk disclosing whether it was produced by grazed or housed cows, or the production system used?
Why does the Red Tractor scheme, which covers 95% of British milk, not require outdoor access or any minimum grazing period for dairy cows?
Why has the Food Standards Agency not updated its position on A1 versus A2 beta-casein since the EFSA review of 2008, despite the publication of multiple peer-reviewed clinical trials in the intervening seventeen years?
Why is there no farm-level antibiotic use reporting requirement for dairy cattle, when such data is essential for monitoring antimicrobial resistance?
Why are British consumers not told that the rBST ban exists, that it protects them from a growth hormone used in US dairy production, and that it is under active trade pressure?
Why does the label on a bottle of British milk not disclose that the product has been standardised, homogenised and pasteurised, and what these processes remove?
Why is the farmgate milk price allowed to function as a supermarket loss-leader, when the documented consequences include mass farm closures, rural economic devastation and elevated suicide rates among farmers?
Why has no British government commissioned a comprehensive review of the nutritional changes in British milk over the past forty years, given the documented effects of breed change, feed change and processing on milk composition?
Call to Action
The bottle of milk in a British family's fridge carries one of the most trusted health reputations of any product in the food system. That reputation was earned by a product and a farming system that, for the majority of British consumers, no longer exists. The milk of 2025 is produced by different cows, on different farms, under different conditions, with a different composition, and the consumer has not been told. This series demands the following.
Mandatory production system labelling on all retail milk, disclosing whether the milk is from grazed, partially housed or zero-grazed cows, the breed profile of the herd and the average herd size.
Mandatory disclosure of antibiotic treatment history at herd level for all milk entering the retail supply chain, with farm-level antibiotic use data collected and published annually for the dairy sector.
A comprehensive FSA review of the A1/A2 beta-casein literature, with public reporting and, if the evidence warrants, mandatory A1/A2 composition labelling.
Legal protection of the rBST ban in primary legislation, removing it from the scope of trade negotiation concessions.
A minimum grazing standard for all dairy cows in the United Kingdom, with Red Tractor certification amended to require outdoor access for a defined minimum period annually.
A statutory minimum farmgate milk price linked to the audited cost of production, preventing supermarkets from using milk as a loss-leader at the expense of farmer viability and welfare.
Public funding for research into minimally processed, microbiologically safe milk products that preserve the bioactive whey proteins associated with reduced asthma and allergy risk in the GABRIELA, PARSIFAL and PASTURE studies.
The British public deserves to know what is in its milk, how it was produced and what has changed. At present, the label on the bottle is a white wall behind which an industry has been transformed, a farming community has been devastated, a product has been degraded, and the consumer has been kept in the dark. It is time to turn the lights on.
Sources
[1] House of Commons Library, UK Dairy Industry Statistics, Research Briefing SN02721.
[2] AHDB, GB Dairy Population: 2024 Figures Mark the Lowest on Record.
[3] AHDB, GB Producer Numbers: Decline Slows but Higher Milk Volumes Indicate Further Consolidation, October 2024.
[4] The Bullvine, The Great UK Dairy Cull: What's Really Driving the Farm Exodus, August 2025.
[5] Fernandez-Rico S et al., The Impact of A1- and A2 Beta-Casein on Health Outcomes: A Comprehensive Review, Applied Sciences 2025; 15(13):7278.
[6] Pal S et al., Effects of Different Cow-Milk Beta-Caseins on the Gut-Brain Axis: A Narrative Review, Nutrition Reviews 2025; 83(3):e1259.
[7] Compassion in World Farming, Nocton Mega-Dairy: New Planning Application - Read the Fine Print, November 2010.
[8] Jan A, Restoring Britain's Health: Article One (Chicken). Previously published in this series.
[9] Jan A, Restoring Britain's Health: Article Five (Bread). Previously published in this series.
[10] Jan A, Restoring Britain's Health: Article Ten (Meat). Previously published in this series.
[11] Dairy Reporter, British Dairy Continues to Consolidate as Producer Numbers Slip, August 2024.
[12] AHDB, GB Producer Numbers: Sharp Decline Indicates Further Consolidation, April 2024.
[13] Farm Safety Foundation / Yellow Wellies, Mind Your Head Campaign and RABI Big Farming Survey, 2022.
[14] FarmingUK, Mental Health Crisis Deepens in UK Farming After 47 Suicides in 2024.
[15] Agriland / Zero Suicide Alliance / BACP, Three People in Agriculture Die by Suicide Every Week.
[16] Ethical Consumer, Dairy Milk Assurance Schemes, 2025.
[17] Wikipedia, Nocton Dairies Controversy (sourced from parliamentary records, planning documents and news reports).
[18] The Ecologist, Why the Victory Over the Nocton Super-Dairy Is Only the Beginning, April 2011.
[19] Compassion in World Farming, Nocton Mega-Dairy Resubmission, November 2010.
[20] The Cattle Site, Plans for UK's Largest Dairy Farm Withdrawn, February 2011.
[21] European Commission, Report on Animal Welfare Aspects of the Use of Bovine Somatotrophin, 1999. Referenced via Bovine Somatotropin Wikipedia article.
[22] Dairy cow productive lifespan data referenced in Compassion in World Farming and CIWF publications.
[23] McCubbin KD et al., Invited Review: Selective Use of Antimicrobials in Dairy Cattle at Drying-Off, Journal of Dairy Science 2022; 105(9):7161-7189.
[24] Higgins HM et al., Understanding Veterinarians' Prescribing Decisions on Antibiotic Dry Cow Therapy, Journal of Dairy Science 2017; 100(4):2909-2916.
[25] University of Minnesota Extension, Selective Dry Cow Therapy.
[26] CAFRE (College of Agriculture, Food and Rural Enterprise), Selective Dry Cow Therapy, 2024.
[27] MSD Animal Health Hub, Improve Cow Health with Selective Dry Cow Therapy.
[28] VMD /
, Veterinary Antimicrobial Resistance and Sales Surveillance Report 2023 (UK-VARSS 2023), published November 2024.
[29]
, UK-VARSS 2023 Highlights.
[30] VMD, Antimicrobial Resistance and Medicine Hub.
[31] Bovine Somatotropin, Wikipedia (comprehensive sourcing from FDA, EU Commission and JECFA documents).
[32] Arla Growth Hormone Monster Advert Banned in US, Farmers Weekly, 2017.
[33] Ohio State University / Codex Alimentarius, rBST Safety Around the World.
[34] Center for Food Safety, About rBGH.
[35] American Cancer Society, Recombinant Bovine Growth Hormone.
[36] ISEP Global / Bovine Hormones: Unpalatable Prospects (post-Brexit trade analysis).
[37] DTN Progressive Farmer, Behind the US-UK Trade Deal, Hormone-Treated Beef Likely Remains a Complication, May 2025.
[38] Frontiers in Nutrition, A2 Milk and BCM-7 Peptide as Emerging Parameters of Milk Quality, 2022.
[39] He M et al., Effects of Cow's Milk Beta-Casein Variants on Symptoms of Milk Intolerance in Chinese Adults, Nutrition Journal 2017; 16:72.
[40] Yun S et al., The Effect of A2 Milk on Gastrointestinal Symptoms in Comparison to A1/A2 Milk, PMC 2024.
[41] Woodford K / Systematic Review of the Gastrointestinal Effects of A1 Compared with A2 Beta-Casein, Advances in Nutrition 2014.
[42] O'Callaghan TF et al., The Grass-Fed Milk Story: Understanding the Impact of Pasture Feeding on Bovine Milk Composition, Nutrients 2019; 11(9):2085.
[43] O'Callaghan TF et al., Effect of Pasture Versus Indoor Feeding Systems on Raw Milk Composition and Quality, Journal of Dairy Science 2016; 99(12):9424-9440.
[44] Benbrook CM et al., Organic Production Enhances Milk Nutritional Quality: US 18-Month Study / Cornucopia Institute summary.
[45] Farming Connect Wales, The Effect of Production System on the Omega-3 and Omega-6 Fatty Acid Profiles of Milk.
[46] Farming Connect Wales, Omega 3 in Milk.
[47] Vitamin K2 in dairy: referenced in First Steps Nutrition and pasture-fed milk literature.
[48] FSA, Raw Drinking Milk and Cream regulations (England and Wales).
[49] Loss G et al., The Protective Effect of Farm Milk Consumption on Childhood Asthma and Atopy: The GABRIELA Study, Journal of Allergy and Clinical Immunology 2011; 128:766-773.
[50] Waser M et al. (PARSIFAL Study), Inverse Association of Farm Milk Consumption with Asthma and Allergy, Clinical and Experimental Allergy 2007; 37:661-670.
[51] von Mutius E and Vercelli D, The Beneficial Effect of Farm Milk Consumption on Asthma: Meta-Analysis, JACI In Practice 2019; 8(3):878-889.
[52] Oster K, xanthine oxidase hypothesis (contested). Referenced in dairy processing literature.
[53] Red Tractor Assurance, Dairy Standards.
[54] Jan A, Restoring Britain's Health: Article Two (Waterways). Previously published in this series.
[55] AHDB and IPCC data on dairy cattle greenhouse gas emissions. Referenced in industry literature.
[56] UK Parliament, Hansard, Mental Health: Farming and Agricultural Communities, Westminster Hall Debate, 11 November 2024.
[57] Time to Change Wales / ONS, Depression and Suicide in Farming Communities (citing ONS 2018 data).
Comments